neurologic disorders
COVID Related Neuropsychiatric Manifestations
Diagnosis of COVID Related Neuropsychiatric Manifestations
Clinical evaluation Testing for other causative disorders MRI of the brain is indicated if patients have focal neurologic deficits and probably if clinicians suspect that neuropsychiatric symptoms are due to acute COVID. If patients have neuropsychiatric symptoms during or after acute COVID, appropriate laboratory testing must also be done to exclude alternative diagnoses (eg, metabolic disorders, CNS infections and structural disorders, psychiatric disorders). The criteria for diagnosis of specific mood disorders (eg, major depressive disorder) and anxiety disorders in patients with COVID are the same as those for other people. If patients have cognitive impairment after acute COVID, neuropsychologic testing may help define cognitive deficits and measure their severity. Standard screening tools should be used to identify patients with anxiety, depression, sleep disturbances, PTSD, dysautonomia, and fatigue. 